Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

Marlton, NJ, March 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it received European CE Mark approval for an expanded indication for the Optimizer® Smart Mini system, which delivers the company’s proprietary CCM® therapy. This new indication now offers millions of patients with diastolic HF a way to alleviate debilitating symptoms, improving their quality of life and reducing hospitalizations related to heart failure.

“This expanded indication addresses an important unmet clinical need for patients with diastolic HF or HF with preserved ejection fraction (HFpEF), as it is now also called,” said Prof. Stefan Anker, MD, of Charité Berlin, Germany. “These patients currently have only a few effective treatment options, therefore, the new development by Impulse Dynamics is most welcome. HF specialists in Europe now have an approved device-based treatment for diastolic HF patients that has been shown to improve quality of life and to reduce their need for HF-related hospitalizations.”

“Impulse Dynamics has established leadership and commitment to significantly changing the treatment options available for HF patients,” said Jason Spees, CEO of Impulse Dynamics. “The expanded indication for CCM therapy in Europe is a reflection of the company’s drive to provide proven treatment solutions for all HF patients.”

HF affects more than 64 million people worldwide and causes symptoms like fatigue, shortness of breath, and swelling that can severely limit daily activities and overall quality of life.[ii] Diastolic HF accounts for almost half of the HF population[iii] and occurs when the heart's ventricles become stiff and unable to relax properly, preventing them from filling with enough blood between beats. These patients have limited treatment options available for managing their symptoms.

In Europe, the OPTIMIZER Smart Mini system is indicated for use in patients who are older than 18 years of age with symptomatic heart failure due to systolic and diastolic left ventricular dysfunction despite appropriate medical therapy. CCM therapy, as delivered by the OPTIMIZER system, has been shown to improve the clinical status, functional capacity, and quality of life, and prevent hospital admissions in patients with symptomatic left heart failure in eligible patients.  

About Impulse Dynamics

Impulse Dynamics is dedicated to advancing the treatment of heart failure (HF) for patients and the healthcare providers who care for them. The company pioneered its proprietary CCM® therapy, which uses the Optimizer® technology platform, to improve quality of life in HF patients. CCM therapy is delivered through the Optimizer system, which includes an implantable pulse generator (IPG) implanted in a minimally invasive procedure and approved for commercial use in the United States and countries worldwide. More than 10,000 patients have received the therapy as part of clinical trials and real-world use, where it is proven to be safe and effective for heart failure patients with debilitating symptoms who otherwise have few effective options available to them. To learn more, visit www.ImpulseDynamics.com, or follow the company on LinkedIn, X (formerly Twitter), and Facebook.

Forward-looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘expect,’’ ‘‘plan,’’ ‘‘anticipate,’’ ‘‘could,’’ ‘‘intend,’’ ‘‘target,’’ ‘‘project,’’ ‘‘contemplate,’’ ‘‘believe,’’ ‘‘estimate,’’ ‘‘predict,’’ ‘‘potential’’ or ‘‘continue’’ or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning potential benefits of CCM therapy. These forward-looking statements are based on management’s current expectations and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Other important factors that could cause actual results, performance or achievements to differ materially from those contemplated in this press release include, without limitation: the company’s future research and development costs, capital requirements and the company’s needs for additional financing; commercial success and market acceptance of CCM therapy; the company’s ability to achieve and maintain adequate levels of coverage or reimbursement for Optimizer systems or any future products the company may seek to commercialize; competitive companies and technologies in the industry; the company’s ability to expand its indications and develop and commercialize additional products and enhancements to its current products; the company’s business model and strategic plans for its products, technologies and business, including its implementation thereof; the company’s ability to expand, manage and maintain its direct sales and marketing organization; the company’s ability to commercialize or obtain regulatory approvals for CCM therapy and its products, or the effect of delays in commercializing or obtaining regulatory approvals; FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets; the timing or likelihood of regulatory filings and approvals; and the company’s ability to establish and maintain intellectual property protection for CCM therapy and products or avoid claims of infringement. The company does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. These forward-looking statements should not be relied upon as representing the company’s views as of any date subsequent to the date of this press release.


[i] Kuschyk, J., Falk, P., Demming, T., Marx, O., Morley, D., Rao, I., & Burkhoff, D. (2021). Long‐term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system. [i]European journal of heart failure23(7), 1160-1169.

[ii] Groenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020). Epidemiology of heart failure. European journal of heart failure22(8), 1342-1356.

[iii] Cleland, J. G. F., Swedberg, K., Follath, F., Komajda, M., Cohen-Solal, A., Aguilar, J. C., ... & Mason, J. (2003). The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis. European heart journal24(5), 442-463.


Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

Rohan More, VP of Global Marketing Impulse Dynamics 856-642-9933 rmore@impulsedynamics.com

THỦ THUẬT HAY

4 cách xử lý iPhone bị đơ khi đang sử dụng

Tình trạng đang sử dụng mà iPhone bị đứng không phải là quá xa lạ. Nếu tình trạng này xảy ra với tần suất thấp thì không có gì phải nói, còn ngược...

Smartphone Android chạy chậm, xử lý làm sao?

Chậm, lag là hiện tượng phổ biến của người dùng smartphone sau một thời gian dài sử dụng, đặc biệt là đối với những điện thoại trong phân khúc giá rẻ và tầm trung. Vậy có cách nào để khắc phục hay không? Cùng tìm hiểu

Hướng dẫn cách gõ tiếng Việt có dấu trên máy tính

Điều kiện cần để bạn có thể gõ được tiếng Việt trên máy tính là phải có cài bộ hỗ trợ gõ tiếng Việt. Có rất nhiều ứng dụng hỗ trợ gõ tiếng Việt nổi bật khác nhau, nhưng chúng tôi chỉ giới thiệu tới các bạn 2 bộ gõ

7 ứng dụng dành cho Android đang miễn phí và giảm giá

Tiếp tục cập nhật danh sách 'Free App' hằng ngày dành cho smartphone Android, TCN đã tổng hợp thêm khá nhiều ứng dụng và game trả phí đang được miễn phí. Nếu bạn quan tâm hãy nhanh tay tải về trước khi bị tính phí trở

Cách cài Windows 10 bằng Hyper-V và cài máy ảo trên Hyper-V

Nếu như bạn đang cần một công cụ, phần mềm để cài Windows 10 hay bất cứ hệ điều hành nào dưới dạng máy ảo thông thường chúng ta sẽ nghĩ đến ngày phần mềm VMWare. Đơn giản vì cài Windows 10 bằng VMWare rất dễ dàng, được

ĐÁNH GIÁ NHANH

So sánh hai mẫu sedan hạng D Mazda6 2.0 và Toyota Camry 2.0E tại Việt Nam

Trong tháng 10 vừa qua, 2 mẫu sedan hạng D là Mazda6 2.0 và Toyota Camry 2.0E mới nhất tại Việt Nam đã được công bố giá bán mới. Phiên bản mới nhất tại thị trường Việt Nam...

Đánh giá Mercedes A45 tại VN - xe thể thao cho người trẻ

A45 trang bị khối động cơ 376 mã lực, có thể tăng tốc từ 0-100 km/h trong 4,2 giây, chở được 5 người lớn cùng hành lý, đủ linh hoạt và dễ điều khiển để có thể sử dụng hàng ngày.

Đánh giá smartphone giải trí Lenovo A7010

Đánh giá smartphone tầm trung Huawei GR5 Đánh giá smartphone selfie Lenovo VIBE S1 Đánh giá smartphone selfie ZTE Blade S7 Đánh giá smartphone Samsung Galaxy S7 Đánh giá bộ đôi máy...